Sort   by:  
 Page size 
ProteomicsAtherosclerotic environment effect over CAC pre-angiogenic role
In response to vascular injury, early EPC or Circulating angiogenic cells (CAC) are thought to be recruited to the damaged areas, participating mainly in a paracrine fashion, by releasing pro-angiogenic factors, promoting the mobilization of other cell populations such as the late EPC, or endothelia...
ORGANISM(S): Homo sapiens (Human) 
2021-09-09 | PXD019395 | Pride
Proteomics Angiogenesis Circulating angiogenic cells Atherosclerotic factors Paracrine role Endothelial colony forming cells Secretome 
UnknownAtherosclerotic Pre-Conditioning Affects the Paracrine Role of Circulating Angiogenic Cells Ex-Vivo.
Not available
S-EPMC7432497 | biostudies-literature
ProteomicsCombined clinical and proteomic data accurately discriminate atherosclerotic versus dyslipidemic patients by application of machine learning tools
BACKGROUND. Atherosclerosis disease results from sustained lipid accumulation within the arterial walls and subsequent chronic inflammatory response, being the major responsible of adverse cardiovascular events with high mortality rates worldwide. An early identification of patients at risk of ather...
ORGANISM(S): Homo sapiens (Human) 
2026-04-13 | PXD049351 | Pride
Human plasma Machine learning Atherosclerosis 
UnknownLymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
Not available
S-EPMC4500593 | biostudies-literature
UnknownApolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774 | biostudies-literature
UnknownSafety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957 | biostudies-literature
UnknownFrequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
Not available
S-EPMC6128696 | biostudies-literature
UnknownInterleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome.
Not available
S-EPMC8387946 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
Sort   by:  
 Page size